Creating a free account will enable you to subscribe to our daily and weekly email newsletters, as well as customize your reading experience to show only the categories most relevant to you.
Signing up only take a few minutes, so why not give it a try and see what you've been missing out on.
Boston College chemists have developed a new chemical synthesis methodology that converts chemicals known as alpha-olefins into new organic compounds. By combining a pair of catalytic reactions in sequence, the researchers converted inexpensive and plentiful chemicals into new boron-containing organic compounds prized by researchers.
The team reports in the online edition of the journal Nature that their advance employed two catalytic reactions - one developed in their Boston College lab and another developed by colleagues at MIT. Combining the two reactions in a sequential process resulted in an unprecedented reaction that offered high levels of purity and selectivity, according to the lead researcher, Boston College Professor of Chemistry James P. Morken.
"We developed the first reaction to convert alpha-olefins into new boron compounds," said Morken. "The second reaction is a palladium-catalyzed reaction that uses a catalyst developed by a team at MIT. Together, these two reactions result in an unprecedented reaction process that works extremely well."
Organic chemists face the challenge of developing new compounds, such as medicines and materials, in a more efficient manner. A driving influence is to produce innovative compounds through simpler, more efficient processes that generate less waste and reduce costs, in particular through the use of readily available chemicals.
The team was surprised by the high level of reactivity in the boron-containing compounds from the first reaction, Morken said. The findings considerably expand the applications of alpha-olefins, a group of organic compounds distinguished by having a double bond at the primary, or alpha, position of their structure. While alpha-olefins are naturally occurring feedstocks that are usually converted into plastics, the increased reactivity that results from adding two boron atoms makes them suitable for wider range of research applications.
Morken said the new methodology should allow for the rapid and efficient production of important compounds from raw chemical feedstocks. As an example, the team used the new process to convert propene gas into phenethylamines, which are an important class of therapeutics, Morken said. In another application, the team used this new method of catalytic reactions to convert another alpha-olefin into pregabalin, which has been used in a variety of pain management drugs.
Morken conducted the research with doctoral students Scott Mlynarski and Chris Schuster, both co-authors of the Nature report.
Asymmetric synthesis from terminal alkenes by cascades of diboration and cross-coupling, Nature (2013) doi:10.1038/nature12781
Article adapted by Medical News Today from original press release. Click 'references' tab above for source.
Visit our Biology / Biochemistry category page for the latest news on this subject.
Please use one of the following formats to cite this article in your essay, paper or report:
College, Boston. "Dual catalysts help synthesize alpha-olefins into new organic compounds." Medical News Today. MediLexicon, Intl., 28 Dec. 2013. Web.
12 Mar. 2014. <http://www.medicalnewstoday.com/releases/270486>
College, B. (2013, December 28). "Dual catalysts help synthesize alpha-olefins into new organic compounds." Medical News Today. Retrieved from
Please note: If no author information is provided, the source is cited instead.
If you write about specific medications, operations, or procedures please do not name healthcare professionals by name.
For any corrections of factual information, or to contact our editorial team, please use our feedback form. Please send any medical news or health news press releases to:
Note: Any medical information published on this website is not intended as a substitute for informed medical advice and you should not take any action before consulting with a health care professional. For more information, please read our terms and conditions.
This page was printed from: http://www.medicalnewstoday.com/releases/270486.php
Visit www.medicalnewstoday.com for medical news and health news headlines posted throughout the day, every day.
© 2004-2014 All rights reserved. MNT (logo) is the registered trade mark of MediLexicon International Limited.